[ad_1]
The extension interval will come to impact from November 11.
“..the competent authority has concurred approval for Dr VG Somani to proceed to carry the cost of the publish of Medicine Controller (India) beneath FR49(v) for an additional interval of three months w.e.f. from 16-11-2022 or till additional order, whichever is earlier,” mentioned Dr Kiran Kumar Karlapu, deputy secretary, Division of Well being and Household Welfare, in his official order.
That is the second extension that Somani obtained. His time period was set to finish on August 14, 2022.
In 2019, the federal government appointed Dr Somani as DCGI for a interval of three years to go India’s apex drug regulatory company Central Medicine Commonplace Management Group (CDSCO).
As the top of CDSCO, the DCGI performs a vital function in making certain high quality of medicines, approves new medication and vaccines and regulates medical trials.
[ad_2]
Source link
